Publications of the Synthetic Biology Group

Showing results 1 - 10 out of 191


Heinemann, H., Zhang, H., & Cox, R. J. (2024). Reductive Release from a Hybrid PKS-NRPS during the Biosynthesis of Pyrichalasin H. Chemistry - a European journal, 30(4), Article e202302590.
Cox, R. J. (2024). Engineered and total biosynthesis of fungal specialized metabolites. Nature Reviews Chemistry, 8(1), 61–78.
Schmidt, K., & Cox, R. J. (2024). Investigation of chain-length selection by the tenellin iterative highly-reducing polyketide synthase. RSC Advances, 14(13), 8963-8970.
Cedeño-Sanchez, M., Cheng, T., Lambert, C., Kolarík, M., Kuhnert, E., Cox, R. J., Kalinowski, J., Verwaaijen, B., & Stadler, M. (2024). Unraveling intragenomic polymorphisms in the high-quality genome of Hypoxylaceae: a comprehensive study of the rDNA cistron. Mycological progress, 23(1), Article 5.


Sun, Y., Gerke, J., Becker, K., Kuhnert, E., Verwaaijen, B., Wibberg, D., Kalinowski, J., Stadler, M., & Cox, R. J. (2023). Rapid discovery of terpene tailoring enzymes for total biosynthesis. Chemical science, 14(46), 13463-13467.
Heinemann, H., Becker, K., Schrey, H., Zeng, H., Stadler, M., & Cox, R. J. (2023). Sporothioethers: deactivated alkyl citrates from the fungus Hypomontagnella monticulosa. RSC Advances, 13(42), 29768-29772.
Fisher, L., Cox, R. J., & Faulds, K. (2023). Introducing transparent peer review to RSC Advances. RSC Advances, 13(32), 21850-21851.
Collin, S., Cox, R. J., Paris, C., Jacob, C., Chagot, B., Weissman, K. J., & Gruez, A. (2023). Decrypting the programming of β-methylation in virginiamycin M biosynthesis. Nature Communications, 14, Article 1327.
Cox, R. J., & Gulder, T. A. M. (2023). Introduction to engineering the biosynthesis of fungal natural products. Natural product reports, 40(1), 7-8.
Reinke, P. Y. A., de Souza, E. E., Günther, S., Falke, S., Lieske, J., Ewert, W., Loboda, J., Herrmann, A., Rahmani Mashhour, A., Karničar, K., Usenik, A., Lindič, N., Sekirnik, A., Botosso, V. F., Santelli, G. M. M., Kapronezai, J., de Araújo, M. V., Silva-Pereira, T. T., Filho, A. F. D. S., ... Meents, A. (2023). Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections. Communications Biology, 6, Article 1058.